Expand ALBO Menu

ALBO Stock Summary and Trading Ideas (Albireo Pharma | NASDAQ:ALBO)

Albireo Pharma (ALBO) Frequently Asked Questions

What does Albireo Pharma do?

Albireo Pharma Inc is a commercial-stage biopharmaceutical company. It focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. The Company's product pipeline includes Bylvay, which is approved in the United States and Europe; elobixibat, which is approved in Japan for the treatment of chronic constipation; A3907, its Phase 1 lead candidate for the treatment of adult liver diseases; and A2342, it's a lead preclinical candidate for the treatment of adult viral and liver diseases.

What symbol and exchange does Albireo Pharma stock trade?

Albireo Pharma trades on the NASDAQ stock market under the symbol ALBO.

What is Albireo Pharma stock price doing today?

As of March 22, 2023, ALBO stock price was flat at $44.15 with million shares trading.

What is Albireo Pharma's Beta?

ALBO has a beta of 0.55, meaning it tends to be less sensitive to market movements. ALBO has a correlation of 0.02 to the broad based SPY ETF.

How much is Albireo Pharma worth?

ALBO has a market cap of $915.89 million. This is considered a Small Cap stock.

How much money does Albireo Pharma make?

Last quarter Albireo Pharma reported $10 million in Revenue and -$1.92 earnings per share. This beat revenue expectation by $292,000 and missed earnings estimates by -$.86.

What is the highest and lowest price Albireo Pharma traded in the last 3 year period?

In the last 3 years, ALBO stock traded as high as $49.00 and as low as $14.37.

What are the top ETFs holding Albireo Pharma?

The top ETF exchange traded funds that ALBO belongs to (by Net Assets): VTI, VXF, NTKI.

Is Albireo Pharma (ALBO) a good investment?

ALBO has outperformed the market in the last year with a price return of +43.3% while the SPY ETF lost -11.3%. ALBO has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +121.1% and 0.0%, respectively, while the SPY returned +3.4% and -1.3%, respectively.

What is the support and resistance for Albireo Pharma (ALBO) stock price?

ALBO support price is $43.90 and resistance is $44.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALBO stock will trade within this expected range on the day.